BMC Medicine (Sep 2020)
Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
- Giovanni Ostuzzi,
- Davide Papola,
- Chiara Gastaldon,
- Georgios Schoretsanitis,
- Federico Bertolini,
- Francesco Amaddeo,
- Alessandro Cuomo,
- Robin Emsley,
- Andrea Fagiolini,
- Giuseppe Imperadore,
- Taishiro Kishimoto,
- Giulia Michencigh,
- Michela Nosé,
- Marianna Purgato,
- Serdar Dursun,
- Brendon Stubbs,
- David Taylor,
- Graham Thornicroft,
- Philip B. Ward,
- Christoph Hiemke,
- Christoph U. Correll,
- Corrado Barbui
Affiliations
- Giovanni Ostuzzi
- WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona
- Davide Papola
- WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona
- Chiara Gastaldon
- WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona
- Georgios Schoretsanitis
- Department of Psychiatry, The Zucker Hillside Hospital
- Federico Bertolini
- WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona
- Francesco Amaddeo
- WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona
- Alessandro Cuomo
- Department of Molecular Medicine, University of Siena
- Robin Emsley
- Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University
- Andrea Fagiolini
- Department of Molecular Medicine, University of Siena
- Giuseppe Imperadore
- Azienda ULSS 9 Scaligera
- Taishiro Kishimoto
- Department of Neuropsychiatry, Keio University School of Medicine
- Giulia Michencigh
- WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona
- Michela Nosé
- WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona
- Marianna Purgato
- WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona
- Serdar Dursun
- Department of Psychiatry, University of Alberta
- Brendon Stubbs
- Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King’s College London
- David Taylor
- Pharmacy Department, Maudsley Hospital
- Graham Thornicroft
- Centre for Global Mental Health and Centre for Implementation Science, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
- Philip B. Ward
- School of Psychiatry, UNSW Sydney and Schizophrenia Research Unit, Ingham Institute of Applied Medical Research
- Christoph Hiemke
- Department of Psychiatry and Psychotherapy, University Medical Center of Mainz
- Christoph U. Correll
- Department of Psychiatry, The Zucker Hillside Hospital
- Corrado Barbui
- WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona
- DOI
- https://doi.org/10.1186/s12916-020-01757-w
- Journal volume & issue
-
Vol. 18,
no. 1
pp. 1 – 1
Abstract
An amendment to this paper has been published and can be accessed via the original article.
